Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0524B vs Atorvastatin in Mixed Hyperlipidemia
NCT00289900Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2006
- Primary completion
- Aug 2010
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of niacin, laropiprant in mixed hyperlipidemia, sponsored by Merck & Co.. Started Jan 2006; status: completed.
02
Drugs
niacinlaropiprant
03
Conditions
mixed hyperlipidemia
Beyond the preview
Go deeper on NCT00289900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289900.